The above seminar was cancelled. You can still find the details if you click on the above link.
This seminar covered the following:
- How U.S. and Chinese governments are cooperating to enhance the safety of drugs and medical devices imported
from China.
- The latest GHTF guidance from the FDAs CDRH Quality System Expert.
- Lessons and experiences from U.S. companies.
- Perspectives from Hong Kong companies.
- Auditing strategies from both FDA & the Far East.
This symposium objectives were the following:
- To communicate the basics of a total lifecycle approach to risk management.
- To discuss the different types of risk related to manufacturing and clinical use of health products.
- To understand how to select the appropriate tools to assess various types of risks.
- To understand approaches for risk modification, mitigation, and control.
- To review continuing education options available for formal education in risk management.